4.5 Article

Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis

Journal

NEUROBIOLOGY OF AGING
Volume 47, Issue -, Pages -

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2016.07.024

Keywords

Sporadic inclusion body myositis; sIBM; SQSTM1; VCP; Genetic risk factor

Funding

  1. University College London (UCL)
  2. Chinese Scholarship Council
  3. Wellcome Trust
  4. National Institute for Health Research (NIHR) Rare Diseases Translational Research Collaboration
  5. NIHR University College London Hospitals (UCLH) Biomedical Research Centre (BRC)
  6. MRC Centre [MR/K000608/01]
  7. MRC grant [MR/J004758/1]
  8. Telethon Italy [GTB12001]
  9. EuroBioBank network [GTB12001]
  10. Medical Research Council [G1001253, G0800674, MR/J004758/1, MR/N003322/1, G0601943, MR/K006312/1, G0802760, G0601943B, MR/K000608/1, G108/638, MR/K000608/1B] Funding Source: researchfish
  11. National Institute for Health Research [CL-2006-06-010, NF-SI-0515-10082] Funding Source: researchfish
  12. MRC [MR/K006312/1, MR/N003322/1, G108/638, G1001253, G0601943, MR/J004758/1, G0802760, G0800674, MR/K000608/1] Funding Source: UKRI

Ask authors/readers for more resources

Genetic factors have been suggested to be involved in the pathogenesis of sporadic inclusion body myositis (sIBM). Sequestosome 1 (SQSTM1) and valosin-containing protein (VCP) are 2 key genes associated with several neurodegenerative disorders but have yet to be thoroughly investigated in sIBM. A candidate gene analysis was conducted using whole-exome sequencing data from 181 sIBM patients, and whole-transcriptome expression analysis was performed in patients with genetic variants of interest. We identified 6 rare missense variants in the SQSTM1 and VCP in 7 sIBM patients (4.0%). Two variants, the SQSTM1 p.G194R and the VCP p.R159C, were significantly overrepresented in this sIBM cohort compared with controls. Five of these variants had been previously reported in patients with degenerative diseases. The messenger RNA levels of major histocompatibility complex genes were upregulated, this elevation being more pronounced in SQSTM1 patient group. We report for the first time potentially pathogenic SQSTM1 variants and expand the spectrum of VCP variants in sIBM. These data suggest that defects in neurodegenerative pathways may confer genetic susceptibility to sIBM and reinforce the mechanistic overlap in these neurodegenerative disorders. (C) 2016 The Author(s). Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available